We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.12B
AUM Growth
–
Cap. Flow
+$1.66B
Cap. Flow %
78.16%
Top 10 Hldgs %
29.11%
Holding
114
New
97
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$77.5M
2
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$72.9M
3
ARRY
Array Biopharma Inc
ARRY
+$58.5M
4
PFE icon
Pfizer
PFE
+$54M
5
NXTM
NxStage Medical Inc.
NXTM
+$49.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 50.73%
2 Technology 1.58%
3 Financials 1.05%
4 Energy 0.02%
5 Consumer Discretionary 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUXL
1
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$80.7M 3.8%
+4,850,644
New +$77.5M
CBST
2
CALL
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$72.4M 3.41%
+1,500,000
New +$73.7M
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
$55.8M 2.63%
+3,909,914
New +$49.2M
PFE icon
4
Pfizer
PFE
$143B
$52M 2.45%
+1,955,170
New +$54M
ARRY
5
DELISTED
Array Biopharma Inc
ARRY
$49.4M 2.33%
+10,885,406
New +$58.5M
TEVA icon
6
Teva Pharmaceuticals
TEVA
$37.3B
$48.7M 2.3%
+1,242,759
New +$48.4M
AZN icon
7
AstraZeneca
AZN
$262B
$43.9M 2.07%
+928,000
New +$47.3M
KERX
8
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$43.8M 2.06%
+5,864,612
New +$45.8M
OPTR
9
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
$43.8M 2.06%
+3,025,829
New +$44.1M
SGNT
10
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$43.7M 2.06%
+2,082,167
New +$37.2M
ATRS
11
DELISTED
Antares Pharma, Inc.
ATRS
$39.1M 1.84%
+9,400,000
New +$36.3M
FRX
12
DELISTED
FOREST LABORATORIES INC
FRX
$38.7M 1.83%
+945,000
New +$36.5M
INFI
13
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$38.1M 1.8%
+2,354,963
New +$72.9M
NKTR icon
14
Nektar Therapeutics
NKTR
$2.31B
$34M 1.6%
+195,983
New +$30.1M
CBST
15
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$33.6M 1.58%
+695,000
New +$34.2M
CAH icon
16
Cardinal Health
CAH
$53.5B
$33M 1.56%
+700,000
New +$32M
AGN
17
DELISTED
Allergan Inc
AGN
$31.6M 1.49%
+375,300
New +$38.9M
ANGO icon
18
AngioDynamics
ANGO
$558M
$29.9M 1.41%
+2,651,466
New +$28.2M
CYH icon
19
Community Health Systems
CYH
$465M
$29.8M 1.41%
+769,710
New +$29M
AIRM
20
DELISTED
Air Methods Corp
AIRM
$29.4M 1.39%
+869,025
New +$33.7M
TRNX
21
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$28.8M 1.36%
+1,646,318
New +$28.3M
UAM
22
DELISTED
Universal American Corp
UAM
$27.2M 1.28%
+3,065,003
New +$27.8M
CTRX
23
CALL
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$26.8M 1.26%
+550,000
New +$28.7M
MRK icon
24
Merck
MRK
$315B
$26.7M 1.26%
+602,600
New +$26.9M
AVDL
25
DELISTED
Avadel Pharmaceuticals
AVDL
$26.6M 1.25%
+4,333,475
New +$22.4M
1
2 3 4

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Deerfield Management, which disclosed 114 positions worth $2.12B. Its ten largest holdings account for 29% of the portfolio.

Its largest position is AUXILIUM PHARAMCEUTICALS INC: 4,850,644 shares worth $80.7M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, followed by Technology and Financials.

  • Deerfield Management's largest Q2 2013 buy was AUXILIUM PHARAMCEUTICALS INC: 4,850,644 shares worth $80.7M.
  • Deerfield Management's ten largest holdings make up 29% of its $2.12B portfolio in Q2 2013.
  • Deerfield Management disclosed 114 positions in Q2 2013, its first 13F filing on record.

Based on Deerfield Management's 13F filing for Q2 2013, filed 14 Aug 2013.